Skip to content
2000
Volume 20, Issue 3
  • ISSN: 1568-0266
  • E-ISSN: 1873-4294

Abstract

The phenylamino-pyrimidine (PAP) nucleus has been demonstrated to be useful for the development of new drugs and is present in a wide variety of antiretroviral agents and tyrosine kinase inhibitors (TKIs). This review aims to evaluate the application of PAP derivatives in drugs and other bioactive compounds. It was concluded that PAP derivatives are still worth exploring, as they may provide highly competitive ATP TKI’s with nano/picomolar activity.

Loading

Article metrics loading...

/content/journals/ctmc/10.2174/1568026620666200124094949
2020-01-01
2025-09-15
Loading full text...

Full text loading...

/content/journals/ctmc/10.2174/1568026620666200124094949
Loading

  • Article Type:
    Review Article
Keyword(s): Antiretroviral; ATP; Cancer; PAP; Pyrimidine; Tyrosine kinase
This is a required field
Please enter a valid email address
Approval was a Success
Invalid data
An Error Occurred
Approval was partially successful, following selected items could not be processed due to error
Please enter a valid_number test